Objective: To observe the alteration of QT dispersion(QTd) and QTc dispersion(QTcd) in hemodialysis patients after oral administration of Zhigancao Decoction(炙甘草汤,Roasted Licorice Decoction,RLD).Methods: T...Objective: To observe the alteration of QT dispersion(QTd) and QTc dispersion(QTcd) in hemodialysis patients after oral administration of Zhigancao Decoction(炙甘草汤,Roasted Licorice Decoction,RLD).Methods: To investigate the alteration of QTd and QTcd in 68 routine hemodialysis patients before and after hemodialysis with 12-lead electrocardiogram(ECG) after orally administrated RLD for 4 weeks.Blood was also taken for measurement of plasma electrolytes,liver function,renal function,hemoglobin(Hgb) and hematocrit(HCT).Results: After hemodialysis,QTd and QTcd were prolonged evidently; the difference was significant between before and after hemodialysis(P〈0.05).After RLD orally administrated for 4 weeks,QTd and QTcd only slightly increased after dialysis compared with pre-dialysis(P〉0.05).The QTd and QTcd of the post-therapy-post-dialysis decreased significantly compared with the pre-therapy-post-dialysis(P〈0.05).There were no other significant changes in other variables(post-therapy-pre-dialysis vs.pre-therapy-pre-dialysis,or post-therapy-post-dialysis vs.pre-therapy-post-dialysis; P〉0.05).After therapy,the number of patients with supraventricular arrhythmia,occasional ventricular premature beat and multiple ventricular premature beat were decreased from 15 to 4,10 to 2 and 7 to 1,respectively.Conclusion: RLD therapy not only lowered the increased QTd and QTcd after hemodialysis,but also displayed a safety profile.展开更多
基金Supported by the National Natural Science Foundation of China(No.81374039)
文摘Objective: To observe the alteration of QT dispersion(QTd) and QTc dispersion(QTcd) in hemodialysis patients after oral administration of Zhigancao Decoction(炙甘草汤,Roasted Licorice Decoction,RLD).Methods: To investigate the alteration of QTd and QTcd in 68 routine hemodialysis patients before and after hemodialysis with 12-lead electrocardiogram(ECG) after orally administrated RLD for 4 weeks.Blood was also taken for measurement of plasma electrolytes,liver function,renal function,hemoglobin(Hgb) and hematocrit(HCT).Results: After hemodialysis,QTd and QTcd were prolonged evidently; the difference was significant between before and after hemodialysis(P〈0.05).After RLD orally administrated for 4 weeks,QTd and QTcd only slightly increased after dialysis compared with pre-dialysis(P〉0.05).The QTd and QTcd of the post-therapy-post-dialysis decreased significantly compared with the pre-therapy-post-dialysis(P〈0.05).There were no other significant changes in other variables(post-therapy-pre-dialysis vs.pre-therapy-pre-dialysis,or post-therapy-post-dialysis vs.pre-therapy-post-dialysis; P〉0.05).After therapy,the number of patients with supraventricular arrhythmia,occasional ventricular premature beat and multiple ventricular premature beat were decreased from 15 to 4,10 to 2 and 7 to 1,respectively.Conclusion: RLD therapy not only lowered the increased QTd and QTcd after hemodialysis,but also displayed a safety profile.